| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |